Estudo randomizado | Irradiação eletiva de linfonodo mamário interno não aumenta a sobrevida livre de doença ou a sobrevida geral na maioria das mulheres com câncer de mama com linfonodo acometido.
27 Out, 2021 | 12:31hEffect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial – JAMA Oncology (gratuito por tempo limitado)
Comentário: No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer — Women with medially or centrally located tumors may be candidates, however, says researcher – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Phase III randomized study evaluated the role of internal mammary node irradiation (IMNI) in node-positive #breastcancer. IMNI did not improve the DFS in unselected patients, but did improve DFS in patients with medially or centrally located tumors https://t.co/tw4ZrHn5wn pic.twitter.com/34ye3TR9MA
— JAMA Oncology (@JAMAOnc) October 25, 2021